BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3517510)

  • 1. Biosynthesis of macrophage activation factor.
    Baliga BS; Rorher SD; Maumenee AE; Peterson RD
    Lymphokine Res; 1986; 5(2):141-56. PubMed ID: 3517510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-GuĂ©rin-immune spleen cell cultures.
    Ruco LP; Meltzer MS
    J Immunol; 1977 Sep; 119(3):889-96. PubMed ID: 330759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
    Nacy CA
    J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
    Schultz RM; Chirigos MA
    Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
    Marino PA; Adams DO
    J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ability of lymphokine and lipopolysaccharide to induce procoagulant activity in mouse macrophage cell lines.
    Farram E; Geczy CL; Moon DK; Hopper K
    J Immunol; 1983 Jun; 130(6):2750-6. PubMed ID: 6602180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage activation to kill Leishmania tropica: kinetics of macrophage response to lymphokines that induce antimicrobial activities against amastigotes.
    Oster CN; Nacy CA
    J Immunol; 1984 Mar; 132(3):1494-500. PubMed ID: 6363544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
    Gilbreath MJ; Nacy CA; Hoover DL; Alving CR; Swartz GM; Meltzer MS
    J Immunol; 1985 May; 134(5):3420-5. PubMed ID: 3980997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular weight, isoelectric point, and stability of a murine lymphokine that induces macrophage tumoricidal activity.
    Yamamoto S; Leonard EJ; Meltzer M
    J Reticuloendothel Soc; 1983 May; 33(5):343-51. PubMed ID: 6341579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.
    Nacy CA; Fortier AH; Meltzer MS; Buchmeier NA; Schreiber RD
    J Immunol; 1985 Nov; 135(5):3505-11. PubMed ID: 3930606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages as cytotoxic effector cells.
    Lohmann-Matthes ML; Lang H; Sun D
    Immunobiology; 1982 Apr; 161(3-4):401-7. PubMed ID: 7047379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing.
    Zhang L; Zhu H; Lun Y; Yan D; Yu L; Du B; Zhu X
    Cell Mol Immunol; 2007 Oct; 4(5):359-67. PubMed ID: 17976316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
    J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
    Meltzer MS; Benjamin WR; Farrar JJ
    J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific surface antigens expressed on activated mouse peritoneal macrophages and recognized by a novel monoclonal antibody.
    Someya A
    Immunology; 1985 Dec; 56(4):683-8. PubMed ID: 3908293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An assay for macrophage activating factor based on the adherence of oil-elicited guinea pig macrophages: characterization of a lymphokine-induced release of hydrogen peroxide from elicited macrophages.
    Talmadge KW; Peck R
    Lymphokine Res; 1986; 5(1):35-47. PubMed ID: 3511329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.